I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| extravillous trophoblast | 3 studies | 48% ± 20% | |
| placental villous trophoblast | 3 studies | 85% ± 15% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| extravillous trophoblast | 3 studies | 48% ± 20% | |
| placental villous trophoblast | 3 studies | 85% ± 15% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| placenta | 3 studies | 48% ± 24% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| bladder | 86% | 485.38 | 18 / 21 | 61% | 105.27 | 307 / 504 |
| lung | 87% | 44.30 | 501 / 578 | 30% | 8.87 | 345 / 1155 |
| pancreas | 53% | 12.99 | 175 / 328 | 61% | 25.35 | 109 / 178 |
| ureter | 0% | 0 | 0 / 0 | 100% | 170.97 | 1 / 1 |
| prostate | 75% | 53.62 | 183 / 245 | 15% | 1.37 | 73 / 502 |
| ovary | 3% | 0.45 | 5 / 180 | 81% | 39.86 | 347 / 430 |
| breast | 58% | 128.19 | 266 / 459 | 24% | 23.90 | 263 / 1118 |
| kidney | 61% | 63.03 | 54 / 89 | 2% | 0.69 | 16 / 901 |
| esophagus | 31% | 20.65 | 441 / 1445 | 19% | 4.43 | 34 / 183 |
| uterus | 6% | 1.78 | 11 / 170 | 39% | 22.42 | 181 / 459 |
| stomach | 27% | 10.02 | 98 / 359 | 13% | 4.54 | 36 / 286 |
| thymus | 4% | 0.67 | 28 / 653 | 22% | 2.83 | 131 / 605 |
| skin | 22% | 5.01 | 401 / 1809 | 0% | 0 | 0 / 472 |
| tonsil | 0% | 0 | 0 / 0 | 11% | 2.04 | 5 / 45 |
| intestine | 0% | 0.06 | 2 / 966 | 10% | 2.94 | 53 / 527 |
| liver | 1% | 0.28 | 3 / 226 | 4% | 1.31 | 18 / 406 |
| adrenal gland | 1% | 0.13 | 2 / 258 | 0% | 0 | 0 / 230 |
| muscle | 1% | 0.09 | 6 / 803 | 0% | 0 | 0 / 0 |
| adipose | 1% | 0.08 | 7 / 1204 | 0% | 0 | 0 / 0 |
| brain | 0% | 0.04 | 8 / 2642 | 0% | 0 | 0 / 705 |
| blood vessel | 0% | 0.07 | 3 / 1335 | 0% | 0 | 0 / 0 |
| heart | 0% | 0.15 | 1 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0.02 | 1 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
| GO_0006355 | Biological process | regulation of DNA-templated transcription |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0003713 | Molecular function | transcription coactivator activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | VGLL1 |
| Protein name | Transcription cofactor vestigial-like protein 1 (Vgl-1) (Protein TONDU) Vestigial like family member 1 Vestigial like 1 (Drosophila), isoform CRA_a (WUGSC:H_GS188P18.1b protein) |
| Synonyms | hCG_33096 WUGSC:H_GS188P18.1b TDU |
| Description | FUNCTION: May act as a specific coactivator for the mammalian TEFs. . FUNCTION: May act as a specific coactivator for the mammalian TEFs. . |
| Accessions | ENST00000370634.8 Q99990 Q99991 ENST00000456412.1 H0Y5G3 Q5H916 ENST00000440515.5 |
